{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:32Z","timestamp":1790651972406,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,22]],"date-time":"2014-06-22T00:00:00Z","timestamp":1403395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00296-014-3066-3","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T10:26:33Z","timestamp":1403346393000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Neuromyelitis optica spectrum disorders associated with other autoimmune diseases"],"prefix":"10.1007","volume":"35","author":[{"given":"Eduardo","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,22]]},"reference":[{"issue":"8","key":"3066_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","volume":"17","author":"J Sellner","year":"2010","unstructured":"Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17(8):1019\u20131032. doi: 10.1111\/j.1468-1331.2010.03066.x","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"3066_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.10.012","volume":"231","author":"R Fazio","year":"2011","unstructured":"Fazio R, Radaelli M, Furlan R (2011) Neuromyelitis optica: concepts in evolution. J Neuroimmunol 231(1\u20132):100\u2013104. doi: 10.1016\/j.jneuroim.2010.10.012","journal-title":"J Neuroimmunol"},{"issue":"9451","key":"3066_CR3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112. doi: 10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"issue":"4","key":"3066_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202(4):473\u2013477. doi: 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"3066_CR5","first-page":"735486","volume":"2012","author":"W Kim","year":"2012","unstructured":"Kim W, Kim SH, Huh SY, Kim HJ (2012) Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int 2012:735486. doi: 10.1155\/2012\/735486","journal-title":"Mult Scler Int"},{"issue":"4","key":"3066_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1155\/2006\/586306","volume":"22","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA (2006) NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers 22(4):197\u2013206","journal-title":"Dis Markers"},{"issue":"1","key":"3066_CR7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78\u201383. doi: 10.1001\/archneurol.2007.17","journal-title":"Arch Neurol"},{"issue":"2","key":"3066_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. doi: 10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"9","key":"3066_CR9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815. doi: 10.1016\/S1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"3066_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2011.01.002","volume":"303","author":"S Mat\u00e0","year":"2011","unstructured":"Mat\u00e0 S, Lolli F (2011) Neuromyelitis optica: an update. J Neurol Sci 303(1\u20132):13\u201321. doi: 10.1016\/j.jns.2011.01.002","journal-title":"J Neurol Sci"},{"issue":"11","key":"3066_CR11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","volume":"256","author":"E Bizzoco","year":"2009","unstructured":"Bizzoco E, Lolli F, Repice AM, Hakiki B, Falcini M, Barilaro A, Taiuti R, Siracusa G, Amato MP, Biagioli T, Lori S, Moretti M, Vinattieri A, Nencini P, Massacesi L, Mata S (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256(11):1891\u20131898. doi: 10.1007\/s00415-009-5171-x","journal-title":"J Neurol"},{"issue":"9","key":"3066_CR12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","volume":"17","author":"S Jarius","year":"2011","unstructured":"Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler (Houndmills, Basingstoke, England) 17(9):1067\u20131073. doi: 10.1177\/1352458511403958","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"8","key":"3066_CR13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/acr.20486","volume":"63","author":"JR Kolfenbach","year":"2011","unstructured":"Kolfenbach JR, Horner BJ, Ferucci ED, West SG (2011) Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis. Arthritis Care Res 63(8):1203\u20131208. doi: 10.1002\/acr.20486","journal-title":"Arthritis Care Res"},{"issue":"1","key":"3066_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","volume":"18","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler (Houndmills, Basingstoke, England) 18(1):5\u201310. doi: 10.1177\/1352458511431077","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"1","key":"3066_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","volume":"39","author":"A McKeon","year":"2009","unstructured":"McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39(1):87\u201390. doi: 10.1002\/mus.21197","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"3066_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2009.08.040","volume":"287","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Mori M, Iwai Y, Kobayashi M, Hayakawa S, Kawaguchi N, Kuwabara S (2009) Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J Neurol Sci 287(1\u20132):105\u2013107. doi: 10.1016\/j.jns.2009.08.040","journal-title":"J Neurol Sci"},{"issue":"8","key":"3066_CR17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458511431728","volume":"18","author":"S Jarius","year":"2012","unstructured":"Jarius S, Paul F, Franciotta D, de Seze J, Munch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (Houndmills, Basingstoke, England) 18(8):1135\u20131143. doi: 10.1177\/1352458511431728","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"20","key":"3066_CR18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","volume":"78","author":"MI Leite","year":"2012","unstructured":"Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78(20):1601\u20131607. doi: 10.1212\/WNL.0b013e31825644ff","journal-title":"Neurology"},{"issue":"1\u20132","key":"3066_CR19","first-page":"148","volume":"275","author":"CS Kay","year":"2008","unstructured":"Kay CS, Scola RH, Lorenzoni PJ, Jarius S, Arruda WO, Werneck LC (2008) NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275(1\u20132):148\u2013150. doi: 10.1016\/j.jns.2008.06.038","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"3066_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2010.07.016","volume":"227","author":"KH Chan","year":"2010","unstructured":"Chan KH, Kwan JS, Ho PW, Ho SL, Chui WH, Chu AC, Ho JW, Zhang WY, Kung MH (2010) Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J Neuroimmunol 227(1\u20132):178\u2013184. doi: 10.1016\/j.jneuroim.2010.07.016","journal-title":"J Neuroimmunol"},{"issue":"9","key":"3066_CR21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","volume":"74","author":"R Klein","year":"2013","unstructured":"Klein R, Marx A, Str\u00f6bel P, Schalke B, Nix W, Willcox N (2013) Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis. Hum Immunol 74(9):1184\u20131193. doi: 10.1016\/j.humimm.2013.06.020","journal-title":"Hum Immunol"},{"key":"3066_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","volume":"1274","author":"A Vincent","year":"2012","unstructured":"Vincent A, Waters P, Leite MI, Jacobson L, Koneczny I, Cossins J, Beeson D (2012) Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann N Y Acad Sci 1274:92\u201398. doi: 10.1111\/j.1749-6632.2012.06789.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"3066_CR23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","volume":"14","author":"A Javed","year":"2008","unstructured":"Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT (2008) Minor salivary gland inflammation in Devic\u2019s disease and longitudinally extensive myelitis. Mult Scler (Houndmills, Basingstoke, England) 14(6):809\u2013814. doi: 10.1177\/1352458508088941","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"9","key":"3066_CR24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/1352458509106636","volume":"15","author":"SM Kim","year":"2009","unstructured":"Kim SM, Waters P, Vincent A, Kim SY, Kim HJ, Hong YH, Park KS, Min JH, Sung JJ, Lee KW (2009) Sjogren\u2019s syndrome myelopathy: spinal cord involvement in Sjogren\u2019s syndrome might be a manifestation of neuromyelitis optica. Mult Scler (Houndmills, Basingstoke, England) 15(9):1062\u20131068. doi: 10.1177\/1352458509106636","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"9","key":"3066_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1352458509106228","volume":"15","author":"JH Min","year":"2009","unstructured":"Min JH, Kim HJ, Kim BJ, Lee KW, Sunwoo IN, Kim SM, Kim BJ, Kim SH, Park MS, Waters P, Vincent A, Sung JJ, Lee KH (2009) Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (Houndmills, Basingstoke, England) 15(9):1069\u20131076. doi: 10.1177\/1352458509106228","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"1","key":"3066_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2006.07.008","volume":"36","author":"F Gokcay","year":"2007","unstructured":"Gokcay F, Celebisoy N, Gokcay A, Kabasakal Y, Oder G (2007) Primary Sjogrens syndrome presenting as neuromyelitis optica. Pediatr Neurol 36(1):58\u201360. doi: 10.1016\/j.pediatrneurol.2006.07.008","journal-title":"Pediatr Neurol"},{"issue":"4","key":"3066_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semarthrit.2010.05.005","volume":"40","author":"JM Kahlenberg","year":"2011","unstructured":"Kahlenberg JM (2011) Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 40(4):343\u2013348. doi: 10.1016\/j.semarthrit.2010.05.005","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3066_CR28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1752-1947-6-401","volume":"6","author":"P Tan","year":"2012","unstructured":"Tan P, Yu WY, Umapathi T, Lim SA (2012) Severe optic neuritis in a patient with combined neuromyelitis optica spectrum disease and primary Sjogren\u2019s syndrome: a case report. J Med Case Rep 6(1):401. doi: 10.1186\/1752-1947-6-401","journal-title":"J Med Case Rep"},{"issue":"6","key":"3066_CR29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/1352458510361740","volume":"16","author":"JH Min","year":"2010","unstructured":"Min JH, Kim SH, Park MS, Kim BJ, Lee KH (2010) Brain MRI lesions characteristic of neuromyelitis optica and positive anti-aquaporin 4-antibody may predict longitudinal extensive myelitis and optic neuritis in Sjogren\u2019s syndrome. Mult Scler (Houndmills, Basingstoke, England) 16(6):762\u2013764. doi: 10.1177\/1352458510361740","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"5","key":"3066_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/s10165-011-0438-3","volume":"21","author":"S Koga","year":"2011","unstructured":"Koga S, Ikeda K, Nakagomi D, Mori M, Kuwabara S, Nakajima H (2011) A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea. Mod Rheumatol\/Jpn Rheum Assoc 21(5):561\u2013562. doi: 10.1007\/s10165-011-0438-3","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc"},{"issue":"5","key":"3066_CR31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3109\/s10165-011-0572-y","volume":"22","author":"Y Katsumata","year":"2012","unstructured":"Katsumata Y, Kawachi I, Kawaguchi Y, Gono T, Ichida H, Hara M, Yamanaka H (2012) Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases. Mod Rheumatol\/Jpn Rheum Assoc 22(5):676\u2013684. doi: 10.1007\/s10165-011-0572-y","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc"},{"issue":"7","key":"3066_CR32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ncprheum0818","volume":"4","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Kerr D (2008) Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol 4(7):381\u2013386. doi: 10.1038\/ncprheum0818","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3","key":"3066_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1352458507084107","volume":"14","author":"LR Mehta","year":"2008","unstructured":"Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schwid SR (2008) Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler (Houndmills, Basingstoke, England) 14(3):425\u2013427. doi: 10.1177\/1352458507084107","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"3","key":"3066_CR34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.autrev.2010.09.021","volume":"10","author":"A Polg\u00e1r","year":"2011","unstructured":"Polg\u00e1r A, R\u00f3zsa C, M\u00fcller V, Matolcsi J, Po\u00f3r G, Kiss EV (2011) Devic\u2019s syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases. Autoimmun Rev 10(3):171\u2013174. doi: 10.1016\/j.autrev.2010.09.021","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3066_CR35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.apme.2013.08.005","volume":"10","author":"VL Arul Selvan","year":"2013","unstructured":"Arul Selvan VL (2013) A case of neuromyelitis optica as a presenting manifestation of systemic lupus erythematosus. Apollo Med 10(3):226\u2013229. doi: 10.1016\/j.apme.2013.08.005","journal-title":"Apollo Med"},{"issue":"10","key":"3066_CR36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s10067-009-1232-x","volume":"28","author":"P Mottaghi","year":"2009","unstructured":"Mottaghi P, Ashtari F, Karimzadeh H, Seidbonakdar Z, Karimifar M, Salesi M (2009) Devic\u2019s syndrome concomitant with nephritis in a young woman. Clin Rheumatol 28(10):1239\u20131240. doi: 10.1007\/s10067-009-1232-x","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"3066_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2011.01.011","volume":"303","author":"D Franciotta","year":"2011","unstructured":"Franciotta D, Zardini E, Caporali R, Piccolo L, Alberici E, Romani A, Bergamaschi R, Marchioni E, Ceroni M, Piccolo G (2011) Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci 303(1\u20132):139\u2013141. doi: 10.1016\/j.jns.2011.01.011","journal-title":"J Neurol Sci"},{"issue":"8","key":"3066_CR38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jocn.2012.09.030","volume":"20","author":"R Sawaya","year":"2013","unstructured":"Sawaya R, Radwan W (2013) Sarcoidosis associated with neuromyelitis optica. J Clin Neurosc 20(8):1156\u20131158. doi: 10.1016\/j.jocn.2012.09.030","journal-title":"J Clin Neurosc"},{"issue":"8","key":"3066_CR39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","volume":"84","author":"A Jacob","year":"2013","unstructured":"Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, de Seze J (2013) Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 84(8):922\u2013930. doi: 10.1136\/jnnp-2012-302310","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"0","key":"3066_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2012.04.027","volume":"415","author":"C Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez C, Gonz\u00e1lez-Buitrago JM, Izquierdo G (2013) Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica. Clin Chim Acta 415(0):350\u2013360. doi: 10.1016\/j.cca.2012.04.027","journal-title":"Clin Chim Acta"},{"issue":"6","key":"3066_CR41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","volume":"125","author":"T Misu","year":"2013","unstructured":"Misu T, Hoftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, Nakashima I, Konno H, Bradl M, Garzuly F, Itoyama Y, Aoki M, Lassmann H (2013) Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 125(6):815\u2013827. doi: 10.1007\/s00401-013-1116-7","journal-title":"Acta Neuropathol"},{"issue":"8","key":"3066_CR42","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","volume":"181","author":"T Vincent","year":"2008","unstructured":"Vincent T, Saikali P, Cayrol R, Roth AD, Bar-Or A, Prat A, Antel JP (2008) Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood\u2013brain barrier permeability and granulocyte recruitment. J Immunol (Baltimore, Md : 1950) 181(8):5730\u20135737","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"3","key":"3066_CR43","first-page":"99","volume":"15","author":"P Waters","year":"2008","unstructured":"Waters P, Vincent A (2008) Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J\/MS Forum 15(3):99\u2013105","journal-title":"Int MS J\/MS Forum"},{"issue":"10","key":"3066_CR44","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archneurol.2010.269","volume":"67","author":"SR Kalluri","year":"2010","unstructured":"Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, Berthele A, Hemmer B (2010) Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol 67(10):1201\u20131208. doi: 10.1001\/archneurol.2010.269","journal-title":"Arch Neurol"},{"issue":"9","key":"3066_CR45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78(9):665\u2013671. doi: 10.1212\/WNL.0b013e318248dec1 (discussion 669)","journal-title":"Neurology"},{"key":"3066_CR46","first-page":"460825","volume":"2012","author":"J Oh","year":"2012","unstructured":"Oh J, Levy M (2012) Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int 2012:460825. doi: 10.1155\/2012\/460825","journal-title":"Neurol Res Int"},{"issue":"2","key":"3066_CR47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1468-1331.2011.03479.x","volume":"19","author":"A Dellavance","year":"2012","unstructured":"Dellavance A, Alvarenga RR, Rodrigues SH, Kok F, de Souza AWS, Andrade LEC (2012) Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases. Eur J Neurol 19(2):248\u2013252. doi: 10.1111\/j.1468-1331.2011.03479.x","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"3066_CR48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 306(1\u20132):82\u201390. doi: 10.1016\/j.jns.2011.03.038","journal-title":"J Neurol Sci"},{"key":"3066_CR49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP, Wildemann B (2010) Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 7:52. doi: 10.1186\/1742-2094-7-52","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3066_CR50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000330240","volume":"19","author":"Y Long","year":"2012","unstructured":"Long Y, Qiu W, Lu Z, Bao J, Wu A, Wang Y, Wang H, Hu X (2012) Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 19(2):96\u2013102. doi: 10.1159\/000330240","journal-title":"Neuroimmunomodulation"},{"key":"3066_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184. doi: 10.1186\/1742-2094-8-184","journal-title":"J Neuroinflammation"},{"key":"3066_CR52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","volume":"421","author":"A Uzawa","year":"2013","unstructured":"Uzawa A, Mori M, Sawai S, Masuda S, Muto M, Uchida T, Ito S, Nomura F, Kuwabara S (2013) Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clin Chim Acta 421:181\u2013183. doi: 10.1016\/j.cca.2013.03.020","journal-title":"Clin Chim Acta"},{"issue":"8","key":"3066_CR53","doi-asserted-by":"crossref","first-page":"e23489","DOI":"10.1371\/journal.pone.0023489","volume":"6","author":"M Storoni","year":"2011","unstructured":"Storoni M, Petzold A, Plant GT (2011) The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis. PLoS One 6(8):e23489. doi: 10.1371\/journal.pone.0023489","journal-title":"PLoS One"},{"key":"3066_CR54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2012.08.041","volume":"226","author":"KC Wang","year":"2012","unstructured":"Wang KC, Tsai CP, Lee CL, Chen SY, Chin LT, Chen SJ (2012) Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Neuroscience 226:510\u2013516. doi: 10.1016\/j.neuroscience.2012.08.041","journal-title":"Neuroscience"},{"issue":"9","key":"3066_CR55","doi-asserted-by":"crossref","first-page":"e74773","DOI":"10.1371\/journal.pone.0074773","volume":"8","author":"JS Tzartos","year":"2013","unstructured":"Tzartos JS, Stergiou C, Kilidireas K, Zisimopoulou P, Thomaidis T, Tzartos SJ (2013) Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders. PLoS One 8(9):e74773. doi: 10.1371\/journal.pone.0074773","journal-title":"PLoS One"},{"issue":"9","key":"3066_CR56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","volume":"14","author":"DH Miller","year":"2008","unstructured":"Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (Houndmills, Basingstoke, England) 14(9):1157\u20131174. doi: 10.1177\/1352458508096878","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"9","key":"3066_CR57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1352458511404917","volume":"17","author":"W Kim","year":"2011","unstructured":"Kim W, Kim SH, Lee SH, Li XF, Kim HJ (2011) Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler (Houndmills, Basingstoke, England) 17(9):1107\u20131112. doi: 10.1177\/1352458511404917","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"7","key":"3066_CR58","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jocn.2012.08.007","volume":"20","author":"JH Min","year":"2013","unstructured":"Min JH, Waters P, Vincent A, Kang ES, Lee S, Lee DK, Lee KH, Kim BJ (2013) Symptomatic brain involvement as the initial manifestation of neuromyelitis optica. J Clin Neurosc 20(7):938\u2013942. doi: 10.1016\/j.jocn.2012.08.007","journal-title":"J Clin Neurosc"},{"issue":"3","key":"3066_CR59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1747-4949.2007.00134.x","volume":"2","author":"W Kuker","year":"2007","unstructured":"Kuker W (2007) Imaging of cerebral vasculitis. Int J Stroke 2(3):184\u2013190. doi: 10.1111\/j.1747-4949.2007.00134.x","journal-title":"Int J Stroke"},{"issue":"5","key":"3066_CR60","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00415-011-6240-5","volume":"259","author":"C Eckstein","year":"2012","unstructured":"Eckstein C, Saidha S, Levy M (2012) A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol 259(5):801\u2013816. doi: 10.1007\/s00415-011-6240-5","journal-title":"J Neurol"},{"issue":"4","key":"3066_CR61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.msard.2012.06.002","volume":"1","author":"DJ Kimbrough","year":"2012","unstructured":"Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Isabel Leite M, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM (2012) Treatment of neuromyelitis optica: review and recommendations. Mult Scler Relat Disord 1(4):180\u2013187. doi: 10.1016\/j.msard.2012.06.002","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"3066_CR62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1352458508100837","volume":"15","author":"M Bonnan","year":"2009","unstructured":"Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P (2009) Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler (Houndmills, Basingstoke, England) 15(4):487\u2013492. doi: 10.1177\/1352458508100837","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"9","key":"3066_CR63","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1352458512471875","volume":"19","author":"YM Lim","year":"2013","unstructured":"Lim YM, Pyun SY, Kang BH, Kim J, Kim KK (2013) Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders. Mult Scler (Houndmills, Basingstoke, England) 19(9):1216\u20131218. doi: 10.1177\/1352458512471875","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"9","key":"3066_CR64","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2169\/internalmedicine.52.7885","volume":"52","author":"H Yaguchi","year":"2013","unstructured":"Yaguchi H, Sakushima K, Takahashi I, Nishimura H, Yashima-Yamada M, Nakamura M, Tsuzaka K, Maruo Y, Takahashi T, Yabe I, Sasaki H (2013) Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Intern Med (Tokyo, Japan) 52(9):969\u2013972","journal-title":"Intern Med (Tokyo, Japan)"},{"issue":"9","key":"3066_CR65","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","volume":"66","author":"A Jacob","year":"2009","unstructured":"Jacob A, Matiello M, Weinshenker BG et al (2009) Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 66(9):1128\u20131133. doi: 10.1001\/archneurol.2009.175","journal-title":"Arch Neurol"},{"issue":"8","key":"3066_CR66","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp-2012-304774","volume":"84","author":"J Kitley","year":"2013","unstructured":"Kitley J, Elsone L, George J, Waters P, Woodhall M, Vincent A, Jacob A, Leite MI, Palace J (2013) Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies. J Neurol Neurosurg Psychiatry 84(8):918\u2013921. doi: 10.1136\/jnnp-2012-304774","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"3066_CR67","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/1352458511404586","volume":"17","author":"GS Bedi","year":"2011","unstructured":"Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA (2011) Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult Scler (Houndmills, Basingstoke, England) 17(10):1225\u20131230. doi: 10.1177\/1352458511404586","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"1\u20132","key":"3066_CR68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2012.09.024","volume":"324","author":"VH Ip","year":"2013","unstructured":"Ip VH, Lau AY, Au LW, Fan FS, Chan AY, Mok VC, Wong KS (2013) Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders. J Neurol Sci 324(1\u20132):38\u201339. doi: 10.1016\/j.jns.2012.09.024","journal-title":"J Neurol Sci"},{"issue":"9","key":"3066_CR69","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00228-013-1518-4","volume":"69","author":"I Danes","year":"2013","unstructured":"Danes I, Agusti A, Vallano A, Martinez J, Alerany C, Ferrer A, Lopez A, Cortes-Hernandez J, Bosch JA (2013) Available evidence and outcome of off-label use of rituximab in clinical practice. Eur J Clin Pharmacol 69(9):1689\u20131699. doi: 10.1007\/s00228-013-1518-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"3066_CR70","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","volume":"12","author":"SJ Pittock","year":"2013","unstructured":"Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O\u2019Toole O, Wingerchuk DM (2013) Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol 12(6):554\u2013562. doi: 10.1016\/s1474-4422(13)70076-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"3066_CR71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","volume":"9","author":"HM Gurcan","year":"2009","unstructured":"Gurcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR (2009) A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 9(1):10\u201325. doi: 10.1016\/j.intimp.2008.10.004","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3066_CR72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3988\/jcn.2013.9.1.36","volume":"9","author":"SH Kim","year":"2013","unstructured":"Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ (2013) Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol (Seoul, Korea) 9(1):36\u201342. doi: 10.3988\/jcn.2013.9.1.36","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"3066_CR73","author":"L Elsone","year":"2013","unstructured":"Elsone L, Panicker J, Mutch K, Boggild M, Appleton R, Jacob A (2013) Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients. Mult Scler. doi: 10.1177\/1352458513495938","journal-title":"Mult Scler"},{"key":"3066_CR74","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es J, S\u00e1 M (2007) Devic disease with abnormal brain magnetic resonance image findings: the first portuguese case. Arch Neurol 64(2):290\u2013291. doi: 10.1001\/archneur.64.2.290","DOI":"10.1001\/archneur.64.2.290"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3066-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3066-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T16:13:55Z","timestamp":1565540035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,22]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3066-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,22]]}}}